Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2003
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines
06/26/2003US20030119183 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
06/26/2003US20030119170 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119161 32132, a novel fucosyltransferase family member and uses therefor
06/26/2003US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
06/26/2003US20030119101 Bactericides, fungicides; transporter proteins
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119078 Method of reducing immunogenicity of toxicity of an antibody of IgG class
06/26/2003US20030119075 Anti-tissue factor antibodies with enhanced anticoagulant potency
06/26/2003US20030119071 Tetrameric antibody complexes for blocking non-specific labeling of antigens
06/26/2003US20030119045 Controlling cell proliferation; adjust adhesion to substrate
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030118659 Antigen-specific induction of peripheral immune tolerance
06/26/2003US20030118657 Treatment of disease states characterized by excessive or inappropriate angiogenesis
06/26/2003US20030118635 Polynucleotide binding complexes comprising sterols and saponins
06/26/2003US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination
06/26/2003US20030118608 Comprising Lelystad Agent in a live, attenuated, dead, or recombinant form
06/26/2003US20030118604 Comprising the 2-45 amino acid sequence of the N-terminal end of the core or nucleocapsid (p21) protein of the hepatitis C virus (HCV), excluding any protein or peptide compound comprising the N-terminal end
06/26/2003US20030118603 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
06/26/2003US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection
06/26/2003US20030118599 Comprising lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cells that expresses such polypeptides, and T cells specific for cells expressing such polypeptides
06/26/2003US20030118597 Beneficial to many patients, primarily due to presence of a number of polypeptides, peptides, enzymes and amines; reduced side effects
06/26/2003US20030118596 Fusion proteins economically synthesized in plants at high levels by biologically contained tobamoviruses; use as antigens for inducing production of antibodies or as vaccine antigens for induction of immunity against parvovirus
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118593 Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
06/26/2003US20030118591 Treatment of severe anthrax infection particularly inhalation pneumonia or gastrointestinal anthrax antigen by passive transfer to infected patients of plasma or derivatives, such as gammaglobulins or antibodies, against bacillus anthracis
06/26/2003US20030118588 Compound comprising an agonist anti-4-1BB antibody, or fragment thereof which stimulates the 4-1BB receptor; for treating tumors or infectious diseases
06/26/2003US20030118583 Performing polypeptide exposure to urea in the presence of a glycine containing solution to deactivate viral contaminants
06/26/2003US20030118582 Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitors
06/26/2003US20030118570 Vectors for tissue-specific replication
06/26/2003US20030118569 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003US20030118564 Intra-tumoral administration of il-12 encoding nucleic acid molecules
06/26/2003US20030118562 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
06/26/2003US20030118549 Removal, contacting with interferon, reinsertion
06/26/2003US20030118546 Genetic engineering; polypeptides; antitumor agent
06/26/2003US20030118509 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2510654A1 Antigens for actinobacillus pleuropneumoniae and methods thereof
06/26/2003CA2473890A1 Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471251A1 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003CA2470645A1 Streptococcus pneumoniae vaccine
06/26/2003CA2470640A1 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2468690A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003CA2467271A1 Mycobacterial vaccine
06/26/2003CA2464512A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine
06/26/2003CA2456830A1 Calcium phosphate particles as mucosal adjuvants
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320552A1 Method for producing human anti-thymocyte immunoglobulins
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320547A1 Transfer factor from birds eggs
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320542A2 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
06/25/2003EP1320381A1 New immunogenic complex
06/25/2003EP1320380A2 Tubulin based vaccine against trypanosomiasis
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320300A1 Food supplement
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP0971703B1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
06/25/2003EP0932411B1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
06/25/2003EP0877807B1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
06/25/2003EP0854924B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
06/25/2003EP0830141B1 Improved virus vaccines
06/25/2003EP0679182B1 Delivery of gene products via mesangial cells
06/25/2003CN1426482A Diagnostics and therapeutics for glaucoma
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426423A Humanized antibodies that sequester amyloid beta peptide
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426309A Adjuvanted genetic vaccines
06/25/2003CN1426307A 蛋白质 Protein
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/25/2003CN1425465A Poly saccharide-protein combination vaccine
06/24/2003US6583268 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics
06/24/2003US6582950 C3 binding polypeptide of Streptococcus agalactiae group b Streptococcus
06/24/2003US6582945 Immunological control of β-amyloid levels in vivo
06/24/2003US6582926 Solid support for use as analytical tool in genetic engineering
06/24/2003US6582925 Desaturase antigen of mycobacterium tuberculosis
06/24/2003US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs
06/24/2003US6582706 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
06/24/2003US6582705 Acellular antibordetella vaccine
06/24/2003US6582704 Immunogenic peptides from the HPV E7 protein
06/24/2003US6582703 Medical diagnosis; amplification primers; genetic engineering
1 ... 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 ... 1823